Navigation Links
More Cancer Lymph Nodes Analyzed at Specialty Centers
Date:7/22/2008

If too few are tested, patient's treatment and prognosis may be affected, study says

TUESDAY, July 22 (HealthDay News) -- Patients with stomach or pancreatic cancer may have more lymph nodes examined for the spread of cancer if they're treated at designated comprehensive cancer centers or at hospitals that do a high number of cancer surgeries, says a U.S. study.

If too few lymph nodes are examined for cancer cells, a patient's cancer may be incorrectly classified, altering prognosis, treatment decisions and eligibility for clinical trials, according to background information in the study. Current guidelines for stomach and pancreatic patients recommend examination of at least 15 regional lymph nodes.

The researchers examined National Cancer Data Base records of 3,088 stomach cancer patients and 1,130 pancreatic cancer patients. Of the stomach cancer patients, 11.6 percent had surgery at a hospital designated as a National Cancer Institute (NCI) comprehensive cancer center or as part of the National Comprehensive Cancer Network (NCCN-NCI hospitals), 34 percent had surgery at other academic hospitals (affiliated with a medical school but not designated as NCCN-NCI facilities), and 54.4 percent had surgery at community hospitals.

Of the pancreatic cancer patients, 19 percent had surgery at NCCN-NCI hospitals, 43.3 percent at other academic hospitals, and 37.7 percent at community hospitals.

"Patients undergoing surgery had more lymph nodes examined at NCCN-NCI hospitals than at community hospitals [median [midpoint], 12 vs. six for gastric cancer and nine vs. six for pancreatic cancer]," wrote Dr. Karl Y. Bilimoria, of the American College of Surgeons and Feinberg School of Medicine at Northwestern University in Chicago, and colleagues. "Patients at the highest-volume hospital had more lymph nodes examined than patients at low-volume hospitals [median, 10 vs. six for gastric cancer and eight vs. six for panc
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Checking more lymph nodes linked to cancer patient survival
2. Has cancer spread? Research identifies best way to find answers so treatment can begin
3. Lung Cancer Trial Targets Asbestos-Related Disease
4. Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
5. Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology
6. New approach to cancer: Find most tightly controlled genes
7. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
8. Weizmann Institute scientists new technique gets to the root of cancer
9. Using magenetic nanoparticles to combat cancer
10. Researchers Find Link Between Organ Transplants, Cancer
11. Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 1DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 3Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 1Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 1Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 3